Market Research Logo

Cerus Corporation (CERS) - Financial and Strategic SWOT Analysis Review

Cerus Corporation (CERS) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Cerus Corporation (Cerus) is a biomedical products manufacturing company which develops and commercializes Intercept Blood System for blood safety. The company has rights of Intercept for three blood components, namely, platelets, red blood cells and plasma. The system is designed to target and inactivate blood-borne pathogens, such as viruses, bacteria, and parasites, as well as harmful white blood cells (WBC) included in donated blood components intended for transfusion. It markets its product in the US, Europe, Russia, the Middle East and selected countries of other regions of the world for the treatment of both platelets and plasma for transfusions and it is also being developed for the treatment of red blood cells. Cerus is headquartered in Concord, California, the US.

Cerus Corporation Key Recent Developments

Mar 08, 2016: Cerus Reports Fourth Quarter and Year End 2015 Results
Jan 11, 2016: Cerus Appoints New Leadership for Europe, Middle East and Africa Region
Jan 05, 2016: Cerus Announces Agreement with Blood Systems for the Use of INTERCEPT Platelets and Plasma
Dec 10, 2015: Cerus Announces Agreement with the National Transfusiology Center of Mongolia for the Use of INTERCEPT Platelets and Plasma
Dec 01, 2015: Cerus and The Community Blood Center Enter into Agreement for the Use of INTERCEPT Platelets and Plasma

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Cerus Corporation - Key Facts
Cerus Corporation - Key Employees
Cerus Corporation - Key Employee Biographies
Cerus Corporation - Major Products and Services
Cerus Corporation - History
Cerus Corporation - Company Statement
Cerus Corporation - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Cerus Corporation - Business Description
Cerus Corporation - Corporate Strategy
Cerus Corporation - SWOT Analysis
SWOT Analysis - Overview
Cerus Corporation - Strengths
Strength - Robust Intellectual Property Portfolio
Strength - Strategic Partnerships
Strength - The INTERCEPT Blood System Technology
Cerus Corporation - Weaknesses
Weakness - History of Losses
Weakness - Concentration of Customers
Cerus Corporation - Opportunities
Opportunity - Product Approvals
Opportunity - CE Label Expands Compatibility
Opportunity - Strategic Agreements
Opportunity - Strategic Partnerships
Cerus Corporation - Threats
Threat - Lack of Manufacturing Facility
Threat - Safety Paradigm
Threat - Competitive Environment
Cerus Corporation - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Cerus Corporation, Medical Equipment, Deals By Year, 2010 to YTD 2016
Cerus Corporation, Medical Equipment, Deals By Type, 2010 to YTD 2016
Cerus Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Cerus Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Cerus Corporation, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 08, 2016: Cerus Reports Fourth Quarter and Year End 2015 Results
Jan 11, 2016: Cerus Appoints New Leadership for Europe, Middle East and Africa Region
Jan 05, 2016: Cerus Announces Agreement with Blood Systems for the Use of INTERCEPT Platelets and Plasma
Dec 10, 2015: Cerus Announces Agreement with the National Transfusiology Center of Mongolia for the Use of INTERCEPT Platelets and Plasma
Dec 01, 2015: Cerus and The Community Blood Center Enter into Agreement for the Use of INTERCEPT Platelets and Plasma
Nov 05, 2015: Cerus Reports Third Quarter 2015 Results
Oct 21, 2015: Cerus Announces New Agreement With Fresenius Kabi for the Production of INTERCEPT Blood System Kits
Aug 06, 2015: Cerus Reports Second Quarter 2015 Results
Jul 13, 2015: Cerus and Bonfils Blood Center Enter Into Agreement for the Use of INTERCEPT Platelets and Plasma
Jun 08, 2015: Richard J. Benjamin, MD PhD Appointed as Cerus Corporation’s New Chief Medical Officer
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Cerus Corporation, Key Facts
Cerus Corporation, Key Employees
Cerus Corporation, Key Employee Biographies
Cerus Corporation, Major Products and Services
Cerus Corporation, History
Cerus Corporation, Subsidiaries
Cerus Corporation, Key Competitors
Cerus Corporation, Ratios based on current share price
Cerus Corporation, Annual Ratios
Cerus Corporation, Interim Ratios
Cerus Corporation, Medical Equipment, Deals By Year, 2010 to YTD 2016
Cerus Corporation, Medical Equipment, Deals By Type, 2010 to YTD 2016
Cerus Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Cerus Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Cerus Corporation, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Cerus Corporation, Performance Chart (2011 - 2015)
Cerus Corporation, Ratio Charts
Cerus Corporation, Medical Equipment, Deals By Year, 2010 to YTD 2016
Cerus Corporation, Medical Equipment, Deals by Type, 2010 to YTD 2016
Cerus Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Cerus Corporation, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report